Consider Recommending a Beta-Blocker for Surgery in High-Risk Patients
New guidelines will clarify when to use beta-blockers for noncardiac surgery.
Beta-blockers reduce the risk of nonfatal heart attack in high-risk patients undergoing noncardiac surgery...probably by decreasing cardiac workload.
But this benefit can come at a cost...bradycardia, hypotension, and possibly a higher risk of stroke and death.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive